undruggable targets

AbbVie, following in footsteps of Lilly and Takeda, pays Anima $42M to go after undruggable targets
Fierce Biotech
Tue, 01/10/23 - 11:05 am
AbbVie
Anima Biotech
MRNA
small molecule drugs
oncology
immunology
undruggable targets
Ventus raises $100M to pursue NLRP3, crack undruggable targets
Fierce Biotech
Thu, 04/8/21 - 10:24 am
Ventus Therapeutics
funding
clinical trials
undruggable targets
FogPharma comes through the clearing with a meaty $107M raise for 'undruggable' targets
Fierce Biotech
Tue, 03/2/21 - 10:57 am
FogPharma
funding
undruggable targets